Skip to content

Zymeworks ZYME Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$102.66M-26.5%-$81.13M-27.9%-$63.43M+13.9%-$73.68M+35.2%-$113.68M+7.3%
$3.65M-0.5%$3.67M-2.6%$3.77M-3.3%$3.9M-5.1%$4.11M-1.9%
$28.57M+1.9%$28.03M+15.8%$24.21M+10.2%$21.96M+6.4%$20.64M+16.0%
-$75.32M-128%-$33.01M+48.6%-$64.26M-65.9%-$38.72M+48.9%-$75.79M+31.1%
$1.72M+13.1%$1.52M+21.3%$1.25M-28.1%$1.74M-4.3%$1.82M-8.5%
$84.44M+217%$26.66M
$158.91M+956%-$18.56M-119%-$8.46M+59.7%-$20.98M+1.3%-$21.25M-4.0%
$168.08M+774%-$24.95M+56.6%-$57.52M
-$77.04M-123%-$34.53M+47.3%-$65.51M-61.9%-$40.47M+47.9%-$77.61M+30.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Zymeworks's cash flow data come from?
Every line is extracted from Zymeworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.